Free Trial

ASML Guidance & Geopolitical Risk For Chipmakers Weighs

EQUITIES

Euro Stoxx 50 futures back below 4,950, with an early bounce form lows quickly fading.

  • Although our technical analyst notes that the bull cycle remains intact in the contract, today’s sell off brings the Jul 2 low (4,903.00) closer.
  • ASML gets most of the attention, with BBG sources noted that “the Biden administration is considering using the most severe trade restrictions available if companies including ASML continue to give China access to advanced semiconductor technology”.
  • That, coupled with disappointing Q3 guidance, weighed on the name, even as Q2 metrics were favourable.
  • The IT sector leads the Stoxx 50 lower as a result.
  • Elsewhere, Roche benefits from positive early-stage test results for a weight loss drug, while Adidas rallies on Q2 earnings and an upgrade for its FY profit outlook.
129 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.

Euro Stoxx 50 futures back below 4,950, with an early bounce form lows quickly fading.

  • Although our technical analyst notes that the bull cycle remains intact in the contract, today’s sell off brings the Jul 2 low (4,903.00) closer.
  • ASML gets most of the attention, with BBG sources noted that “the Biden administration is considering using the most severe trade restrictions available if companies including ASML continue to give China access to advanced semiconductor technology”.
  • That, coupled with disappointing Q3 guidance, weighed on the name, even as Q2 metrics were favourable.
  • The IT sector leads the Stoxx 50 lower as a result.
  • Elsewhere, Roche benefits from positive early-stage test results for a weight loss drug, while Adidas rallies on Q2 earnings and an upgrade for its FY profit outlook.